Ramiven 150mg Tablet

Ramiven 150mg Tablet

16500 INR

Product Details:

  • Salt Composition Abemaciclib
  • Indication Breast cancer treatment
  • Dosage Form Tablet
  • Feature Other
  • Ingredients Other
  • Application Other
  • Physical Color/Texture Film-coated tablet
  • Click to view more
X

Ramiven 150mg Tablet Price And Quantity

  • 50 Box
  • 16500 INR

Ramiven 150mg Tablet Product Specifications

  • Other
  • Refer to package
  • Breast cancer treatment
  • Store below 30C
  • Other
  • Tablet
  • Other
  • Abemaciclib
  • Film-coated tablet
  • Film-coated
  • 14 tablets
  • Oval
  • Oncology drug
  • 150 mg
  • 150 mg
  • Abemaciclib Tablets
  • Stripe
  • Oral

Ramiven 150mg Tablet Trade Information

  • Cash in Advance (CID)
  • 100 Box Per Month
  • 7 Days
  • All India

Product Description



Jump on the opportunity for instant savings with Ramiven 150mg Tablet - a kingly choice in oncology care. Crafted for outstanding performance, this affordable, lofty solution is formulated with Abemaciclib to provide reliable support in advanced breast cancer treatment. Each stripe contains 14 oval, film-coated tablets, marked '150 mg' for easy identification. Administered orally, this prescription medicine ensures efficacy while offering convenience and discretion. Store below 30C and refer to the package for shelf life. Exported and supplied directly from trusted Indian manufacturers.

Key Features and Usage of Ramiven 150mg Tablet

Ramiven 150mg Tablet features advanced Abemaciclib composition, specifically crafted as a film-coated, oral-use tablet for oncology applications. It is tailor-made for breast cancer treatment, ensuring patients benefit from top-tier therapeutic performance. The tablet is to be used strictly under medical supervision, following prescription guidelines, and supports an established oncological regimen. Used as part of a comprehensive cancer care plan, it offers consistent dosage and effective management for patients in need.


FOB Port, Domestic Market Rates & Certifications

Ramiven 150mg Tablet is available for shipment from leading Indian FOB ports, ensuring prompt and reliable global distribution. The product is widely recognized in the domestic mar due to its competitive rates and outstanding efficacy. It complies with stringent quality certifications, reinforcing its reputation among reputable exporters, manufacturers, and suppliers. Bulk orders can be processed efficiently, guaranteeing that each shipment meets the high standards expected in oncology pharmacotherapy worldwide.


FAQ's of Ramiven 150mg Tablet:


Q: How should Ramiven 150mg Tablet be administered for best results?

A: Ramiven 150mg Tablet should be taken orally as directed by a healthcare professional. It is important to follow the prescribed dosage and administration schedule to optimize treatment outcomes.

Q: What are the main benefits of using Ramiven 150mg Tablet for breast cancer treatment?

A: Ramiven 150mg Tablet delivers targeted breast cancer therapy with Abemaciclib, offering outstanding efficacy and supporting improved disease management as part of a prescribed oncology regimen.

Q: When is it indicated to start treatment with Ramiven 150mg Tablet?

A: Ramiven 150mg Tablet is indicated for patients with certain advanced or metastatic types of breast cancer, as determined by an oncologist based on individual case assessments.

Q: Where can I source Ramiven 150mg Tablet for export and supply?

A: Ramiven 150mg Tablet can be sourced from certified exporters, manufacturers, and suppliers in India who provide reliable, quality-assured shipments for both domestic and international markets.

Q: What is the storage requirement for Ramiven 150mg Tablet?

A: Ramiven 150mg Tablet should be stored below 30C and kept in its original packaging to maintain its stability. Always refer to the package for specific shelf life information.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Anti Cancer Medicine' category



Back to top